1. Home
  2. WFCF vs INMB Comparison

WFCF vs INMB Comparison

Compare WFCF & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WFCF

Where Food Comes From Inc.

N/A

Current Price

$12.83

Market Cap

59.1M

Sector

Technology

ML Signal

N/A

Logo INmune Bio Inc. Common stock

INMB

INmune Bio Inc. Common stock

HOLD

Current Price

$2.25

Market Cap

49.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
INMB
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.1M
49.2M
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
WFCF
INMB
Price
$12.83
$2.25
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$4.30
AVG Volume (30 Days)
3.8K
480.6K
Earning Date
11-13-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
45.82
N/A
EPS
0.53
N/A
Revenue
$25,512,000.00
$50,000.00
Revenue This Year
N/A
$173.21
Revenue Next Year
N/A
$12,733.99
P/E Ratio
$24.90
N/A
Revenue Growth
N/A
19.05
52 Week Low
$9.26
$1.38
52 Week High
$13.78
$11.64

Technical Indicators

Market Signals
Indicator
WFCF
INMB
Relative Strength Index (RSI) 63.28 74.00
Support Level $12.50 $1.54
Resistance Level $13.15 $2.26
Average True Range (ATR) 0.41 0.15
MACD 0.15 0.09
Stochastic Oscillator 100.00 97.53

Price Performance

Historical Comparison
WFCF
INMB

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.

About INMB INmune Bio Inc. Common stock

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Share on Social Networks: